1 |
Gao F, Xu YL, Liu YJ, Sun MH. Outcomes of self-expandable metal stent placement for malignant oesophageal strictures. Clin Radiol 2020;75:156.e21-7. [PMID: 31703807 DOI: 10.1016/j.crad.2019.10.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Abdelshafy M, Omar MA, Abdel Bary M, Wahaman MM, Bakheet RAE. Self-expandable metal stent for palliation of malignant dysphagia & quality of life improvement in advanced cancer esophagus: Upper Egypt experience. Journal of the Egyptian Society of Cardio-Thoracic Surgery 2017;25:262-9. [DOI: 10.1016/j.jescts.2017.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
3 |
Medeiros VS, Martins BC, Lenz L, Ribeiro MSI, de Paulo GA, Lima MS, Safatle-Ribeiro AV, Kawaguti FS, Pennacchi C, Geiger SN, Bastos VR, Ribeiro-Junior U, Sallum RA, Maluf-Filho F. Adverse events of self-expandable esophageal metallic stents in patients with long-term survival from advanced malignant disease. Gastrointest Endosc 2017;86:299-306. [PMID: 28024985 DOI: 10.1016/j.gie.2016.12.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
4 |
Jung K, Ahn JY, Jung HY, Cho CJ, Na HK, Jung KW, Lee JH, Kim do H, Choi KD, Song HJ, Lee GH, Kim JH. Outcomes of endoscopically inserted self-expandable metal stents in malignancy according to the type of stent and the site of obstruction. Surg Endosc 2016;30:4001-10. [PMID: 26715018 DOI: 10.1007/s00464-015-4712-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
5 |
Jung K, Ahn JY, Jung H, Cho CJ, Na HK, Jung KW, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH, Kim J. Outcomes of endoscopically inserted self-expandable metal stents in malignancy according to the type of stent and the site of obstruction. Surg Endosc 2016;30:4001-10. [DOI: 10.1007/s00464-015-4712-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
6 |
Kim JY, Kim SG, Lim JH, Im JP, Kim JS, Jung HC. Clinical outcomes of esophageal stents in patients with malignant esophageal obstruction according to palliative additional treatment. J Dig Dis 2015;16:575-84. [PMID: 26316005 DOI: 10.1111/1751-2980.12280] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
7 |
Park JH, Song HY, Shin JH, Cho YC, Kim JH, Kim SH, Park J. Migration of retrievable expandable metallic stents inserted for malignant esophageal strictures: incidence, management, and prognostic factors in 332 patients. AJR Am J Roentgenol 2015;204:1109-14. [PMID: 25905949 DOI: 10.2214/AJR.14.13172] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
8 |
Kang HW, Kim SG. Upper Gastrointestinal Stent Insertion in Malignant and Benign Disorders. Clin Endosc 2015;48:187-93. [PMID: 26064817 DOI: 10.5946/ce.2015.48.3.187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
9 |
Kang HW, Kim SG. Upper Gastrointestinal Stent Insertion in Malignant and Benign Disorders. Clin Endosc. 2015;48:187-193. [PMID: 26064817 DOI: 10.5946/ce.2015.48.3.187] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
|
10 |
Baron TH. Radiation therapy and esophageal endoprosthetics: Facts and fiction. Techniques in Gastrointestinal Endoscopy 2014;16:89-91. [DOI: 10.1016/j.tgie.2014.05.001] [Reference Citation Analysis]
|
11 |
Kim MD, Park SB, Kang DH, Lee JH, Choi CW, Kim HW, Chung CU, Jeong YI. Double layered self-expanding metal stents for malignant esophageal obstruction, especially across the gastroesophageal junction. World J Gastroenterol 2012; 18(28): 3732-3737 [PMID: 22851867 DOI: 10.3748/wjg.v18.i28.3732] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
12 |
Brimhall B, Adler DG. Enteral stents for malignant gastric outlet obstruction. Gastrointest Endosc Clin N Am 2011;21:389-403, vii-viii. [PMID: 21684461 DOI: 10.1016/j.giec.2011.04.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
|
13 |
Tougeron D, Richer JP, Silvain C. Management of esophageal adenocarcinoma. J Visc Surg. 2011;148:e161-e170. [PMID: 21715236 DOI: 10.1016/j.jviscsurg.2011.05.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
14 |
Tougeron D, Richer J, Silvain C. Traitement des adénocarcinomes de l’œsophage. Journal de Chirurgie Viscérale 2011;148:184-195. [DOI: 10.1016/j.jchirv.2011.03.011] [Reference Citation Analysis]
|
15 |
. Current world literature. Curr Opin Support Palliat Care 2011;5:65-8. [PMID: 21321522 DOI: 10.1097/SPC.0b013e3283440ea5] [Reference Citation Analysis]
|